Hilfestellung zur Diabetestherapie in häuslicher Quarantäne während einer Pandemie
Across the world more than 420 million people are living with diabetes. Two thirds of these have not yet been diagnosed. When discovered late or managed incorrectly, diabetes can damage your heart, blood vessels, eyes, kidneys, and nerves, leading to disability and premature death. In fact, more peo...ple are dying of diabetes related diseases than of diseases as HIV/AIDS, malaria and tuberculosis combined.
more
Lancet Glob Health 2020Published OnlineNovember 27, 2020 https://doi.org/10.1016/S2214-109X(20)30449-6
Available in Englisch, Spanish and Portuguese
Recommendations on the management of diabetes mellitis during the COVID-19 pandemic
Position Statement
Diabetes Care2018;42(Suppl. 1):S1–S194.
A Manual for Medical Officer
Developed under the Government of India – WHO Collaborative Programme 2008-2009
Accessed: 11.03.2019
1st edition
This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation
Guide des éléments essentiels pour une bonne pratique - Première édition 2019
Ce guide a été conçu afin d’apporter les informations nécessaires à une prise en charge pratique et exhaustive des personnes atteintes de diabète et de tuberculose. Il s’appuie sur les résultats d’étude...s publiées, sur l’opinion d’experts ainsi que sur l’expérience pratique.
more
Dieser E-Learning-Kurs verschafft Ihnen durch informative Texte, anschauliche Fallbeispiele und nützliche Links einen umfassenden Überblick zur Diabetes-Situation weltweit. Der Schwerpunkt liegt dabei auf dem globalen Süden. Praktische Hilfestellungen für Ihre Arbeit runden das Angebot ab. Für ...die Bearbeitung der gesamten E-Learning Einheit benötigen Sie etwa zweieinhalb Stunden.
Modul A: Überblick zur aktuellen Situation; Folgen für Länder des globalen Südens (Daür: ca. 15 Min.);
Modul B: Medizinische Grundlagen; Ursachen und Komplikationen; Zusammenhänge mit nfektionskrankheiten (Daür: ca. 30 Min.); Modul C: Grundlagen von Diagnose, Behandlung und Schulung; Präventionsmaßnahmen; Probleme beim Zugang zu Medikamenten (Daür: ca. 30 Min.); Modul D: Nutzen und Schaden gängiger Antidiabetika, rationale Auswahl von Medikamenten (Daür: ca. 30 Min.); Modul E: Globale Verbreitung von Diabetes; Länderstudien; politischen Gegenmaßnahmen und WHO-Pläne (Daür: ca. 30 Min.); Modul F: Praktische Hilfestellungen für die Arbeit (Daür: ca. 15 Min.)
more
Lancet Glob Health 2018, Published Online September 12, 2018 http://dx.doi.org/10.1016/S2214-109X(18)30387-5
This is an abridged version of the 2019 Standards containing the evidence-based recommendations most pertinent to primary care. The tables and figures have been renum-bered from the original document to match this version. The complete 2019 Standards of Care do...cument, including all supporting references, is available at professional.diabetes.org/standards.
This is an abridged version of the American Diabetes Association’s Standards of Medical Care in Diabetes—2019. Diabetes Care2018;42(Suppl. 1):S1–S194. The complete 2019 Standards supplement, including all supporting references, is available at professional.diabetes.org/standards.
more
Cardiovascular disease, diabetes, chronic obstructive pulmonary disease, cancers, and other non-communicable diseases are among the leading causes of morbidity and mortality in low-income, middle-income, and high-income countries, and The Lancet Taskforce recently made the case for investing in non-...communicable disease prevention. Now, in The Lancet Planetary Health, Benjamin Bowe and colleagues report that exposure to PM2·5 air pollution is indeed a risk factor for diabetes.
more
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...nterventions (WHO PEN) for primary care in low-resources settings, reviewing several newer oral agents as second- and third-line treatment: dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter 2 inhibitors and thiazolidinediones. The guidelines also present recommendations on the selection of type of insulin (analogue versus human insulin) for adults with type 1 and type 2 diabetes.
more